Related Experiment Video
Updated: Jun 6, 2026

Modulation of Tau Subcellular Localization as a Tool to Investigate the Expression of Disease-related Genes
Published on: December 20, 2019
Localisation of Neuregulin 1-β3 to different sub-nuclear structures alters gene expression
Ming Wang1, Carol M Trim, William J Gullick
1Cancer Biology Laboratory, School of Biosciences, University of Kent, Canterbury, Kent, CT2 7NJ, UK.
Abstract:
Neuregulins are growth factors that signal via the ErbB3 and ErbB4 receptors. Here we show using immunohistochemistry that they are often expressed in the nucleus of a range of tumour types including soft tissue and breast. The Neuregulin 1 type I-β3 (NRG1-β3) isoform localises to two sub-nuclear compartments in animal cells, nucleoli and spliceosomes. We used NRG1-β3 tagged with photoactivatable GFP and demonstrated that this re-localised from nucleoli to spliceosomes over 90 min. Tyrosine kinase activity was not required for retaining the NRG1-β3 within the nucleus. Mutation of the lysines 14 and 16 or 15 and 16 together prevented nucleolar uptake while four positively charged residues were identified which were required for spliceosome uptake. Molecular modelling suggests that three of these may form a binding site. We showed using a kinome array that NRG1-β3 and a mutant exclusively localising to spliceosomes increased phosphorylation and/or expression of the HER4 and HER2 receptors. Using a transcriptomic analysis the same two constructs induced expression of several messenger RNAs and we confirmed the increased expression at the protein level of the most highly induced, Heat Shock Protein 70B'. These results suggest that Neuregulin activates receptor signalling in spliceosomes leading to altered gene expression.
Insights
Neuregulins, growth factors, are found in tumor cell nuclei and regulate gene expression via spliceosomes. This study reveals their nuclear localization and impact on receptor signaling, offering new therapeutic targets.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Neuregulins are growth factors that activate ErbB3 and ErbB4 receptors.
- Nuclear localization of neuregulins in various tumor types suggests novel intracellular functions.
- Understanding neuregulin's nuclear role is crucial for cancer biology.
Purpose of the Study:
- To investigate the sub-nuclear localization and function of Neuregulin 1 type I-β3 (NRG1-β3).
- To determine the mechanisms of NRG1-β3 nuclear import and retention.
- To elucidate NRG1-β3's role in receptor signaling and gene expression.
Main Methods:
- Immunohistochemistry to detect nuclear neuregulin expression in tumors.
- Utilized photoactivatable GFP-tagged NRG1-β3 to track its sub-nuclear re-localization.
- Employing site-directed mutagenesis to identify key residues for nuclear localization.
- Kinome array and transcriptomic analysis to assess downstream signaling and gene expression changes.
Main Results:
- NRG1-β3 localizes to nucleoli and spliceosomes within the nucleus.
- Nuclear retention of NRG1-β3 is independent of tyrosine kinase activity.
- Specific lysine mutations affect nucleolar and spliceosomal uptake, identifying key residues.
- NRG1-β3 activates HER4 and HER2 receptor signaling and induces Heat Shock Protein 70B' expression.
Conclusions:
- Neuregulin signaling can be activated within spliceosomes, independent of canonical cell surface receptor activation.
- Nuclear neuregulin functions suggest a novel mechanism for regulating gene expression in cancer.
- These findings open new avenues for targeting nuclear neuregulin pathways in oncology.
Related Concept Videos
Chromatin Position Affects Gene Expression
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the timing and level of...
The Nucleolus
Regulation of Nuclear Protein Sorting
Regulated mRNA Transport
Regulation of Expression at Multiple Steps
Nuclear Localization Signals and Import

